Maftivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).[1][2]
This antiinfective drug article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 18.219.244.45